Refreshing results…
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
UploadAcquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts
UploadTP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence
UploadTargeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma
UploadA distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia
Download from doi.orgOvercoming IMiD Resistance in T-cell Lymphomas Through Potent Degradation of ZFP91 and IKZF1
Download from ashpublications.orgReduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia
UploadGenomic Landscape of Young ATLL Patients Identifies Frequent Targetable CD28 Fusions
UploadMechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents
Download from aacrjournals.orgMissing publications? Search for publications with a matching author name.